Fundraising Foxpi Ventures — 2025 Investments
6 investments dated 2025 · listed companies and verified rows first · show all
Immunito AI is an in-silico antibody discovery company that combines artificial intelligence with an in-house biological lab to speed up and improve the discovery of antibodies.
AI & Machine LearningBiotechDeep TechMedical DevicesBangalore, IN
Trisha Chatterjee(Co-Founder and CTO)inAridni Shah(Co-Founder and CEO)in
Co-investorsEntrepreneur First3one4 CapitalAC VenturesAnicut Capital
LightSpeed Photonics builds modular optoelectronic processors and optical interconnects aimed at bandwidth-intensive computing workloads.
Advanced ManufacturingDeep TechMedia & EntertainmentBangalore, IN
Rohin Yelurpati(CEO)inDinesh Natesan(Cofounder)inRohin Kumar
Co-investors500 GlobalEntrepreneur FirstMerak Ventures8X VenturesApplied VenturesgrowX Ventures+2 more
Moonrider is an automotive company developing electric tractors.
AgTechCleantechHardwareMobility & TransportationBangalore, IN
Ravi Kulkarni(Founder)inAnoop Srikantaswamy Ravi Kulkarni(Founder)
Co-investorsAdvantedge FoundersAxilor Ventures
Ottonomy builds autonomous delivery robots (Ottobots) using contextual AI and L4 autonomy for indoor and outdoor last-mile transport across hospitals, labs, pharmacies, manufacturing plants, campuses, and urban areas.
AI & Machine LearningLogistics & Supply ChainRoboticsSanta Monica, US
Hardik Sharma(Director)Ashish Gupta(Director)Pradvot Korupolu Venkata Narasimha(Executive Officer, Director)Ritukar Vijay(Executive Officer, Director)
Co-investorsBranded Strategic HospitalityConnetic VenturesWellstar
Repello provides autonomous red teaming and security testing for AI applications and agents, detecting vulnerabilities through adversarial attack simulation combined with human-like interaction testing.
AI & Machine LearningCybersecurityEnterprise SoftwareBangalore, IN
Aryaman Behera(Founder)inNaman Mishra(Founder)inAryaman Behera Naman Mishra(Founder)
Co-investorsEntrepreneur FirstCharlie SonghurstVenture Highway
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.